Levosimendan Administration in Pulmonary Hypertension
Status:
Recruiting
Trial end date:
2022-10-17
Target enrollment:
Participant gender:
Summary
The aim of the study is to examine the pharmacokinetics and pharmacodynamic properties of
Levosimendan in cardiac surgery patients with pulmonary hypertension and impaired right
ventricular function.